Top Markets
Coin of the day
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
Rang in Aktien #4732
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aktienkurs
$48.46
Marktkapitalisierung
$3.35B
Veränderung (1 Tag)
-1.09%
Veränderung (1 Jahr)
186.60%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)

Kategorie

Kursverlauf für Pulse Biosciences, Inc. (PLSE)
Höchster Schlusskurs: $45.60 am 2026-08-01

Niedrigster Schlusskurs: $4.20 am 2016-05-01
Kursverlauf der Aktie von Pulse Biosciences, Inc. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 52.89%
2025 -23.80%
2024 72.60%
2023 322.28%
2022 -84.88%
2021 -15.48%
2020 41.40%
2019 19.04%
2018 -50.17%
2017 306.74%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$369.77 -21.52%
US
$188.84 -39.14%
FR
$162.42 24.54%
JP
$190.25 23.84%
US
$76.21 -6.76%
CH